Breast cancer incidence in Spain drops in early 2000s after decades of increasing rates

	Tweet

After a steady increase of invasive breast cancer cases in Spanish women during the 1980s and 1990s, incidence rates abruptly declined starting in 2001—a trend most likely explained by a period effect linked to screening saturation, according to a new study published online October 26 in the .

Marina Pollán, M.D., Ph.D., of the Centro Nacional de Epidemiología, Instituto de Salud Carlos III in Madrid, and colleagues identified invasive breast cancer cases from population-based cancer registries in Spain that had at least 10 years of uninterrupted registration over the period 1980჻�. The researchers took into account the starting year of the corresponding breast cancer screening program for the population and the year in which the screening program achieved full coverage of the target population.

Overall incidence rates rose by 2.9% annually during the 1980s and 1990s, but there was a statistically significant change in this trend in 2001, when incidence declined annually by 3.0%. There was a steady increase in incidence for women younger than 45 years, an abrupt downturn in 2001 for women aged 45㈞ years, and a gradual leveling off in 1995 for women aged 65 years or older.

The sharp decline could be a result of the introduction of screening programs, according to the authors. When screening programs are introduced, cancer incidence can rise because diagnoses occur earlier than they would have without screening. But this rise is temporary.

“Once the program is in place and screening coverage of the target population reaches a plateau, incidence rates tend to decrease because the pool of undiagnosed prevalent cases has been reduced,” the authors write. “We found that the change point in breast cancer incidence in Spain occurred in 2001, but this overall trend is likely to be the consequence of changes acting on different age groups and regions at different times.”

###

Contact: Press officer: Milagros Iglesias, , 34-91822 24 51 and author Marina Pollán,

Note to Reporters: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage.

Visit JNCI online at http://jnci.oxfordjournals.org and the JNCI press room at http://www.oxfordjournals.org/our_journals/jnci/press_room.html

For the latest cancer news and studies, follow our Twitter account @JNCI_Now!

Contact: Steve Graff

301-841-1285
Journal of the National Cancer Institute

RELATED STORIES:
Breast Cancer Survivors Lack Critical Information about Reducing Recurrence   Breast cancer: A new treatment avenue identified   BUSM study shows patient navigations improve mammography rates in minority women   3-week radiation therapy as effective as 5 weeks for early-stage breast cancer   Breast cancer surgery decisions difficult for many   Chemoprevention biomarker for breast cancer identified   The protein TXNL2 provides human breast cancer cells with protection   Many Women Who Had Childhood Cancer Do Not Undergo Breast Cancer Screening   Computer Based Model Helps Radiologists Diagnose Breast Cancer   Racial disparities seen in male breast cancer survival   Mammograms on the rise for foreign-born women living in the US   Systematic estimation of breast cancer risk appears justified in postmenopausal women   Breast cancer doesn’t have to mean losing your breast   Breast Brachytherapy Use Outpaces Evidence   Contralateral Prophylactic Mastectomy Associated with Survival in Select Group of Breast Cancer   Linchpin Gene May Be Useful Target For Breast Cancer Therapies   New possibilities for breast cancer treatment on the horizon   Women Treated for Breast Cancer While Pregnant Have Improved Survival   Multiple Childbirth Linked to Rare but Aggressive ‘Triple-Negative’ Breast Cancer   Immigrants from India, Pakistan Face U.S. Prostate, Breast Cancer Risks   Normal Tissue Not Spared in New Forms of Breast Cancer Radiotherapy   Cell Study Finds Receptor Can Fight Tamoxifen-resistant Breast Cancer Cells

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]